Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor
Pfizer Inc. and Ranbaxy Inc. were hit Friday with a proposed class action alleging drug wholesalers overpaid billions of dollars for the high-cholesterol medicine Lipitor because of a purported pay-for-delay scheme...To view the full article, register now.
Already a subscriber? Click here to view full article